Physician profile

Eric L Diamond

Podiatrist · Westminster, MD

NPI 1629075262

$248.92

in general payments reported to CMS, 2019-2025

10 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$48.22

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Ortho Dermatologics, A Division of Bausch Health US, LLC $40.02 2019
Nevro Corp. $34.92 2024 Senza
Sandoz INC. $33.71 2019
Hikma Pharmaceuticals USA $25.29 2019-2021
Stryker Corporation $23.95 2019
Melinta Therapeutics, LLC $22.08 2019
Zyla Life Sciences, INC. $21.71 2019
Sebela Pharmaceuticals INC. $17.95 2019
Merck Sharp & Dohme LLC $15.99 2019
Smith+Nephew, INC. $13.30 2023 Collagenase Santyl

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Eric L Diamond

$248.92

in general payments reported 2019-2025

Years
2019-2024
Top company
Ortho Dermatologics, A Division of Bausch Health US, LLC

https://glasscript.com/doctor/346518/eric-l-diamond

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.